Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Published 2016 View Full Article

Authors

Keywords

Phase I, Palbociclib, Cetuximab, Head and neck cancer, Squamous cell carcinoma

Journal

ORAL ONCOLOGY

Volume 58, Issue -, Pages 41-48

Publisher

Elsevier BV

Online

2016-05-28

DOI

10.1016/j.oraloncology.2016.05.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started